EDUCATIONAL FOUND OF OSAKA MEDICAL & PHARMACEUTICAL UNIV has a total of 12 patent applications. It increased the IP activity by 500.0%. Its first patent ever was published in 2015. It filed its patents most often in Japan. Its main competitors in its focus markets pharmaceuticals, medical technology and textiles and paper are GEISTLICH SOEHNE AG, ALTMAN GREGORY H and LYNCH SAMUEL E.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 12 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Textiles and paper | |
#4 | Biotechnology | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Object sterilising | |
#3 | Therapeutic chemical compounds | |
#4 | Special textiles | |
#5 | Peptides | |
#6 | Climate change mitigation in goods production | |
#7 | Implantable devices | |
#8 | Knitting |
# | Name | Total Patents |
---|---|---|
#1 | Yamada Goji | 2 |
#2 | Kadota Kazunori | 2 |
#3 | Kikuchi Takashi | 2 |
#4 | Totsuka Yuichi | 2 |
#5 | Otsuki Shuhei | 2 |
#6 | Hirano Yoshiaki | 1 |
#7 | Tatsumi Kazunori | 1 |
#8 | Hamazono Toshiro | 1 |
#9 | Tomota Kiichiro | 1 |
#10 | Sakurai Jun | 1 |
Publication | Filing date | Title |
---|---|---|
JP2020188833A | Pharmaceutical composition for joint disease treatment and method for producing same | |
JP2020147509A | Anticancer agent | |
JP2020080922A | Meniscus regeneration base material | |
JP2020026408A | Skin aging inhibitor and elastase inhibitory activity agent | |
JP2019205633A | Cardiac function analyzer, analysis method, program and recording medium | |
JP2019199413A | Agent for the prevention or treatment of gb3 accumulation-attributable disease | |
JP2019196342A | Statin-encapsulated nanoparticle preparation, dental pulp-derived stem cells containing the same, and cell preparation containing the same | |
JP2019083907A | Topical injection needle | |
JP2018078860A | Oral composition | |
JP2017193519A | Anticancer agent | |
JP2017071559A | Tranilast-diphenhydramine coamorphous |